.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The recently launched Lipid Interactome platform offers an open-access portal for investigating the complex relationships between lipids and proteins. Lipid-protein interactions are essential for cellular signaling and maintaining membrane dynamics. However, the biochemical properties of lipids have historically made these interactions difficult to characterize. This new resource provides a centralized database to harmonize and compare diverse proteomics datasets efficiently.
Modern proteomics identification relies on advanced functionalized lipid probes. These probes utilize photoactivatable crosslinkers and affinity handles to identify binding partners with high resolution. Furthermore, the Lipid Interactome platform organizes this data according to FAIR principles, meaning it is Findable, Accessible, Interoperable, and Reusable. Consequently, researchers in India and worldwide can now perform direct cross-study comparisons of bioactive lipids without navigating fragmented repositories.
The database uses standardized formatting and interactive visualizations to simplify complex data. Moreover, it consolidates information from multiple studies, providing a holistic view of the lipid interactome. This consolidation is crucial for deciphering biological functions in health and disease. Therefore, this tool serves as a bridge between basic biochemistry and clinical applications in metabolic and oncological research.
The platform currently hosts curated datasets from various lipid interactome studies. Users can explore specific protein-binding partners through study-specific analysis pages. Additionally, no user registration is required to navigate the portal or download data. This open-access model encourages widespread collaboration and accelerates the validation of candidate lipid-binding proteins.
The platform serves as a centralized, interactive web portal to harmonize and visualize lipid-protein interaction data derived from proteomics studies, making research data more accessible and comparable.
Functionalized lipid probes are synthetic analogs equipped with chemical groups like diazirines for crosslinking and alkynes for enrichment. These tools allow researchers to capture and identify proteins that interact with specific lipids in live cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Lipid Interactome is a new open-access web portal designed to harmonize and visualize lipid-protein interaction data for medical researchers....
8 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Recent clinical studies reveal maternal autoantibodies targeting IL-1RA as potential triggers for preterm labor, opening avenues for targeted cytokine therapies. Concurrently, new perioperative findings show inhaled cannabis increases propofol requirements during upper endoscopy compared to oral edible consumption.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
